D-Dimera sangotesto post 50: klarigo pri aĝaj limoj

Kategorioj
Artikoloj
Tromba risko Interpretado de Laboratoriaj Rezultoj Ĝisdatigo de 2026 Pacient-ĝentila

A mildly high D-dimer at 72 is not interpreted the same way as the same number at 32. The hard part is knowing when age adjustment is safe — and when symptoms override the maths.

📖 ~12 minutoj 📅
📝 Publikigita: 🩺 Medicina revizio: ✅ Bazita sur evidenteco
⚡ Rapida Resumo v1.0 —
  1. D-dimera sangoanalizo measures fibrin breakdown; a high result suggests clot formation and breakdown somewhere, but it does not prove a clot.
  2. Standard cutoff is often 500 ng/mL FEU, also written as 0.50 mg/L FEU, but labs use different units.
  3. Age-adjusted D-dimer cutoff after age 50 is usually age × 10 ng/mL FEU; a 78-year-old may have a cutoff of 780 ng/mL FEU.
  4. D-dimer cutoff by age should only be used when clinical probability is low or intermediate, not when symptoms strongly suggest pulmonary embolism or DVT.
  5. Urgent imaging is still needed for chest pain, sudden breathlessness, fainting, low oxygen, coughing blood, or a swollen painful leg, even with a borderline D-dimer.
  6. FEU kontraŭ DDU-unuoj matter because FEU values are roughly twice DDU values; 500 ng/mL FEU is about 250 ng/mL DDU.
  7. Pli aĝaj plenkreskuloj often run higher because baseline fibrin turnover, vascular tissue response, kidney clearance changes, cancer risk, and infection rates rise with age.
  8. Limrezultoj are safest when interpreted with Wells or Geneva score, oxygen saturation, pulse rate, risk factors, and timing of symptoms.

What a D-dimer blood test means after age 50

After age 50, a D-dimera sangoanalizo can be interpreted with an age-adjusted cutoff: age × 10 ng/mL FEU. So a 70-year-old may be considered negative below 700 ng/mL FEU if clot probability is low or intermediate. But symptoms win. New breathlessness, chest pain, fainting, low oxygen, coughing blood, or one swollen painful leg still need urgent imaging, even when the number is only borderline.

D-dimer blood test visualized as a fibrin fragment assay in a clean alpine laboratory
Figuro 1: Fibrin fragment testing links clot breakdown with clinical risk assessment.

I’m Thomas Klein, MD, and in clinical review work I see the same trap every week: a 76-year-old with a D-dimer of 620 ng/mL FEU is told it is “high,” then panics. At age 76, the age-adjusted cutoff is 760 ng/mL FEU, so 620 can be negative only when the clinical picture is reassuring.

A D-dimer result above 500 ng/mL FEU is common after 65, and that is why a fixed adult cutoff creates many false alarms. Our physician team, including reviewers listed on the medicina konsila komitato, treats D-dimer as a rule-out test, not a diagnosis.

Kantesti is an AI blood test analyzer that reads D-dimer alongside age, units, symptoms, pregnancy or surgery status, kidney markers, and inflammatory markers. That context matters because a 520 ng/mL FEU result in a calm 52-year-old is different from the same value in an 82-year-old with oxygen saturation of 90%.

Why D-dimer results often run higher as people age

D-dimer rises with age because older blood vessels and tissues have more background fibrin formation and breakdown. The rise is usually not one single problem; it is the combined effect of vascular aging, chronic inflammation, slower clearance, more medical procedures, and more silent illness.

D-dimer blood test context shown with aging vessel tissue and fibrin turnover illustration
Figuro 2: Ageing tissue can increase baseline fibrin turnover without proving thrombosis.

By the late 60s, many healthy people have small increases in coagulation activation markers even without a deep vein thrombosis or pulmonary embolism. That does not mean the body is “full of clots”; it means the haemostatic system is noisier than it was at age 30.

The practical problem is specificity. In older adults, a fixed 500 ng/mL FEU cutoff can label a large proportion of non-clot illnesses as positive, especially pneumonia, heart failure, kidney impairment, cancer, trauma, and recent hospital admission. For a broader patient view, our normala intervalo de D-dimero guide explains why “normal” is not always one number.

I often describe D-dimer as smoke, not fire. Smoke may come from a dangerous pulmonary embolism, but it may also come from a recent infection with CRP of 80 mg/L or a fall with bruising 5 days earlier. The number asks for clinical reasoning; it does not replace it.

How the age-adjusted D-dimer cutoff is calculated

La kutima age-adjusted D-dimer cutoff after 50 is age × 10 ng/mL FEU. A 60-year-old uses 600 ng/mL FEU, a 75-year-old uses 750 ng/mL FEU, and an 88-year-old uses 880 ng/mL FEU when the assay reports FEU units.

D-dimer blood test age cutoff calculation shown with citrate tube and age bands
Figuro 3: Age adjustment changes the cutoff while keeping symptom risk central.

The ADJUST-PE study in JAMA found that age-adjusted cutoffs safely increased the number of older patients in whom pulmonary embolism could be ruled out without CT imaging (Righini et al., 2014). In patients 75 or older, the proportion ruled out by D-dimer rose from about 6.4% with the 500 ng/mL FEU cutoff to 29.7% using age adjustment.

Kantesti’s neural network treats this as D-dimer cutoff by age, not as a universal green light. A result of 690 ng/mL FEU at age 70 may be below the 700 cutoff, but only if the pretest probability is not high and the sample was taken before anticoagulation.

If you are comparing several biomarkers, age adjustment should sit beside the rest of the panel, not in a mental silo. Our biomarkila gvidilo is built around that same principle: one result changes meaning when paired with age, kidney function, inflammation, and symptoms.

A useful bedside trick is to ignore the last digit of age and add a zero. Age 63 becomes about 630 ng/mL FEU; age 81 becomes about 810 ng/mL FEU. I still check the unit before saying anything reassuring.

Age 52 example 520 ng/mL FEU A value below this may be negative if clot probability is low or intermediate.
Age 65 example 650 ng/mL FEU Mildly above 500 may still be below the age-adjusted threshold.
Age 75 example 750 ng/mL FEU This is where age adjustment often prevents unnecessary CT imaging.
Age 88 example 880 ng/mL FEU Still unsafe to use if symptoms or Wells score suggest high probability.

FEU versus DDU units can double the apparent number

D-dimer reports are usually shown as FEU or DDU, and 500 ng/mL FEU is roughly equivalent to 250 ng/mL DDU. Misreading the unit can make a result look twice as high or falsely reassuring.

D-dimer blood test units compared using paired assay trays and blank lab materials
Figuro 4: FEU and DDU units can make the same result look different.

FEU means fibrinogen equivalent units; DDU means D-dimer units. Most age-adjusted formulas are published as ng/mL FEU, so the standard 500 ng/mL FEU cutoff becomes age × 10 after 50.

If your lab uses DDU, the rough equivalent age-adjusted cutoff is age × 5 ng/mL DDU. A 72-year-old cutoff would be about 720 ng/mL FEU or 360 ng/mL DDU, though assay-specific calibration still matters.

This is where many “D-dimer test results explained” summaries fail patients: they quote a single cutoff without unit conversion. Our gvidilo pri koaguliĝa testado compares D-dimer with PT, INR, aPTT, and fibrinogen because clotting reports often arrive as a cluster.

Some European laboratories report mg/L FEU, where 0.50 mg/L FEU equals 500 ng/mL FEU. A report of 0.68 mg/L FEU at age 70 is 680 ng/mL FEU, which sits below the age-adjusted 700 ng/mL FEU cutoff if the clinical probability is low.

FEU ng/mL 500 ng/mL FEU Common fixed adult cutoff; age-adjusted cutoff after 50 is age × 10.
FEU mg/L 0.50 mg/L FEU Same as 500 ng/mL FEU; age 70 cutoff is 0.70 mg/L FEU.
DDU ng/mL 250 ng/mL DDU Roughly half the FEU value; age-adjusted estimate is age × 5.
Assay-specific reporting Varies by method Always use the cutoff printed by the lab when available.

Age adjustment is safe only after pretest probability is checked

Age-adjusted D-dimer is validated for patients with low or intermediate clinical probability, not for people who already look likely to have a clot. Doctors usually combine symptoms, pulse, oxygen level, prior clot history, cancer, surgery, immobilisation, and exam findings before trusting the cutoff.

D-dimer blood test assessed beside clinical probability tools in a consultation scene
Figuro 5: D-dimer interpretation starts with clinical probability, not the number alone.

The 2019 European Society of Cardiology pulmonary embolism guideline supports D-dimer testing only in low or intermediate probability patients; high probability patients should generally proceed to imaging (Konstantinides et al., 2020). That distinction prevents a normal or borderline result from delaying diagnosis.

The PEGeD trial in the New England Journal of Medicine also showed that D-dimer can be adjusted to clinical probability, with higher thresholds used in low-risk patients under structured rules (Kearon et al., 2019). This is not “guesswork”; it is formal risk sorting.

For clinicians, Wells score remains a practical shorthand: signs of DVT, heart rate above 100/min, immobilisation, previous VTE, haemoptysis, cancer, and whether PE is the most likely diagnosis. Our research-style koaguliĝa signa gvidilo goes deeper into how D-dimer sits beside protein C and aPTT.

In my experience, the unsafe cases are rarely subtle in hindsight. A patient with pleuritic chest pain, tachycardia of 118/min, and oxygen saturation of 91% should not be reassured by a D-dimer of 610 ng/mL FEU at age 68.

Symptoms that still require urgent clot imaging

Urgent imaging is needed when symptoms suggest pulmonary embolism or deep vein thrombosis, even if D-dimer is borderline or below an age-adjusted cutoff. Sudden breathlessness, chest pain with breathing, fainting, low oxygen, coughing blood, rapid pulse, or one swollen painful leg should be treated as time-sensitive.

D-dimer blood test interpretation shown with lung imaging and urgent symptom cues
Figuro 6: Borderline D-dimer results cannot override high-risk symptoms.

A pulmonary embolism can present with oxygen saturation below 92%, pulse above 100/min, sharp chest pain, new breathlessness, or collapse. A normal chest X-ray does not rule it out, and a borderline D-dimer does not make a high-risk story disappear.

In Kantesti clinical review, we flag symptom combinations rather than chasing the D-dimer number alone. A 58-year-old with a D-dimer of 540 ng/mL FEU and haemoptysis needs a different pathway than a 58-year-old with 540 after a mild viral illness and no cardiopulmonary symptoms.

Our deeper article on high D-dimer symptoms is useful because it separates laboratory risk from symptom risk. The two overlap, but they are not identical.

If you have severe breathlessness, fainting, blue lips, chest pressure, confusion, or a leg that is rapidly swelling, this is emergency territory. Do not wait 24 hours for a repeat D-dimer; imaging and clinical assessment are the safer next step.

One swollen leg can need ultrasound despite a borderline result

A single swollen, painful calf or thigh can still need venous ultrasound even when D-dimer is only mildly raised. DVT risk is higher when swelling is one-sided, new, tender, associated with warmth, or occurs after immobilisation, surgery, long travel, cancer, pregnancy, or prior clot.

D-dimer blood test paired with venous ultrasound assessment for one swollen leg
Figuro 7: Ultrasound is often the decisive test for one-sided leg swelling.

DVT is not diagnosed by D-dimer; it is diagnosed by compression ultrasound in the right clinical setting. A proximal DVT in the thigh is usually more dangerous than an isolated calf clot because it has a higher chance of embolising to the lungs.

The clinical clue I trust most is asymmetry. A calf circumference difference of more than 3 cm, measured about 10 cm below the tibial tuberosity, is part of Wells scoring for DVT and changes the meaning of a borderline D-dimer.

Not all swelling is clot-related, of course. Low albumin, kidney disease, heart failure, lymphatic disease, and medication-related oedema can mimic or confuse the picture; our swelling lab clues guide covers those non-clot causes.

The tricky scenario is the older patient on a diuretic with chronic ankle swelling who notices one leg became worse over 48 hours. I would not let an age-adjusted D-dimer alone settle that case; ultrasound is cheap, fast, and often definitive.

Common non-clot reasons D-dimer is high in older adults

D-dimer can be high without a dangerous clot because many illnesses activate fibrin turnover. Infection, cancer, recent surgery, trauma, heart failure, kidney impairment, liver disease, inflammatory disorders, stroke, and hospitalisation can all push D-dimer above 500 ng/mL FEU.

D-dimer blood test molecules shown among immune response and fibrin fragments
Figuro 8: Many tissue-response states increase fibrin breakdown markers.

The number tends to rise with severity. A mild chest infection may produce 700 ng/mL FEU, while sepsis, advanced cancer, or major trauma can produce several thousand ng/mL FEU without the result telling you exactly where the problem is.

Inflammation and coagulation talk to each other. When CRP is 100 mg/L and white blood cells are 16 × 10⁹/L, D-dimer may reflect systemic tissue response rather than a primary clot; our infekta signa gvidilo explains that pattern.

Kidney function matters too. Reduced eGFR can correlate with higher D-dimer partly because older, frailer patients have more vascular disease and inflammatory burden, and partly because clearance of several proteins becomes less predictable.

The clinical mistake is assuming “not a clot” means “nothing.” A D-dimer of 2,400 ng/mL FEU with fever, weight loss, anaemia, or abnormal liver enzymes still deserves work-up, just not necessarily a CT pulmonary angiogram as the first move.

Pregnancy, surgery, and infection change the rules

Age-adjusted D-dimer cutoffs are not a simple fit for pregnancy, the first weeks after surgery, or recent significant infection. In these settings, D-dimer often rises because coagulation and tissue repair are expected to be active.

D-dimer blood test considered after surgery and infection recovery in a calm clinical scene
Figuro 9: Recent procedures and infections can make D-dimer less specific.

After major surgery, D-dimer can remain elevated for days to weeks, sometimes above 1,000 ng/mL FEU even without a new clot. The exact timeline depends on tissue injury, immobility, infection, and whether preventive anticoagulation was used.

Pregnancy is a separate diagnostic pathway. D-dimer rises across trimesters, and clinicians may use pregnancy-adapted algorithms rather than the standard age × 10 rule; our article on pregnancy and surgery explains those exceptions.

COVID and other infections can leave a tail of raised D-dimer. A result of 900 ng/mL FEU 10 days after a febrile illness may reflect recovery, but new chest pain or falling oxygen saturation changes the risk immediately.

I try to pin down timing: symptom day 1, surgery day 14, flight day 3, fever day 7. D-dimer loses meaning when the timeline is vague because the same value can be harmless recovery noise or the early clue to a clot.

When D-dimer can look falsely reassuring

A D-dimer can be falsely low or less helpful if symptoms have been present for many days, anticoagulants were started before the test, the clot is small or isolated, or the assay has limited sensitivity. A negative result lowers risk; it does not erase a high-risk story.

D-dimer blood test shown beside anticoagulant timing and delayed symptom clues
Figuro 10: Timing and prior anticoagulants can make D-dimer less reliable.

D-dimer is most useful early in evaluation, before treatment. If someone took therapeutic anticoagulation for 24 to 48 hours before testing, the fibrin breakdown signal may fall enough to make interpretation less clean.

Symptoms that started 10 to 14 days earlier can also muddy the water. A clot may have stabilised, partially resolved, or produced less measurable D-dimer by the time the person finally attends clinic.

Kantesti is an AI-powered blood test analysis tool used by patients in more than 127 countries, but our outputs are designed to flag uncertainty rather than give a clot diagnosis. The teknologia gvidilo explains how our system separates lab interpretation from emergency decision-making.

A clinician who hears “I fainted yesterday and now cannot walk across the room” should not be comforted by a borderline D-dimer. That case needs examination, oxygen measurement, ECG, and often imaging.

What urgent clot imaging usually involves

Urgent imaging for suspected pulmonary embolism is usually CT pulmonary angiography, V/Q scanning, or compression ultrasound depending on symptoms, pregnancy status, kidney function, contrast allergy, and local availability. The D-dimer result helps decide whether imaging is needed; it does not choose the scan by itself.

D-dimer blood test workflow leading to CT and ultrasound imaging options
Figuro 11: Imaging choice depends on symptoms, kidneys, pregnancy status, and contrast risk.

CT pulmonary angiography is fast and widely used, but it requires iodinated contrast and exposes the chest to radiation. In a patient with eGFR below 30 mL/min/1.73 m², contrast risk becomes part of the decision.

V/Q scanning can be useful when CT contrast is not ideal, particularly if the chest X-ray is normal. A leg ultrasound may confirm DVT and justify treatment without chest CT in selected cases.

Before imaging, doctors often check creatinine, eGFR, pregnancy status where relevant, oxygen saturation, ECG, and sometimes troponin or BNP if PE strain is suspected. Our rena rezultgvidilo helps patients understand why renal numbers suddenly matter before contrast.

If imaging confirms PE, the next decision is severity. A small stable PE with oxygen saturation 97% is different from a large PE with low blood pressure, raised troponin, and right-heart strain.

How AI interpretation should handle D-dimer context

AI interpretation should treat D-dimer as a context-dependent marker, not as a binary high-or-normal label. The safest output considers age, units, assay type, timing, symptoms, risk factors, and related labs such as CRP, CBC, creatinine, platelets, PT/INR, and fibrinogen.

D-dimer blood test evaluated with contextual lab markers in an AI review workflow
Figuro 12: Context-aware interpretation prevents overreacting to isolated D-dimer flags.

Kantesti is an AI lab test interpretation service that can identify when a D-dimer is above the lab’s fixed cutoff but below an age-adjusted threshold. That distinction is useful because many lab portals mark 510 ng/mL FEU as abnormal without explaining age.

The second layer is safety wording. If symptoms entered by the user include chest pain, shortness of breath, fainting, coughing blood, or unilateral leg swelling, the system should point toward urgent clinical evaluation rather than “watch and wait.”

Nia AI interpretado-limoj article is blunt about this: AI can explain patterns in about 60 seconds, but it cannot listen to your lungs, measure oxygen, or decide whether a CT scanner is needed tonight.

In my own review queue, the most useful AI flag is not “D-dimer high.” It is “D-dimer high for this age and paired with symptoms that raise clot probability,” which is a much more clinically honest sentence.

When repeating D-dimer helps — and when it wastes time

Repeating D-dimer can help when the original result was drawn too early, reported in confusing units, or obtained during a clear temporary trigger. Repeating it is not appropriate when current symptoms suggest PE or DVT; imaging should not be delayed for a second number.

D-dimer blood test repeat decision shown with timing pathway and fibrin fragments
Figuro 13: Repeat testing helps only when symptoms are low risk and timing is unclear.

A repeat test after 1 to 2 weeks can be reasonable when D-dimer was mildly raised during a viral illness and symptoms have fully settled. Falling from 1,100 to 520 ng/mL FEU can support recovery, though it still does not diagnose what happened.

Repeating is less helpful after surgery because values may stay high for several weeks. A stable patient 10 days post-operation needs risk assessment and sometimes ultrasound, not daily D-dimer checks.

Patients often ask for a second set of eyes when the portal says “abnormal” but the doctor says “not worrying.” Our dua opinio guide explains when that kind of review is useful and when same-day care is safer.

If you repeat D-dimer, repeat it in the same unit system if possible. Comparing 0.74 mg/L FEU with 390 ng/mL DDU without conversion is a recipe for confusion.

Questions to ask when your D-dimer is borderline

A borderline D-dimer should prompt better questions, not automatic reassurance or automatic CT scanning. Ask about the unit, your age-adjusted cutoff, your Wells or Geneva risk, symptom timing, recent triggers, and what symptom change should send you to urgent care.

D-dimer blood test discussion shown during a patient-clinician results review
Figuro 14: The best follow-up questions turn a borderline result into a plan.

The first question is simple: “Is this FEU or DDU?” The second is, “What cutoff applies for my age?” A 69-year-old with 640 ng/mL FEU may be below age-adjusted cutoff, while 640 ng/mL DDU is a different level of concern.

Then ask, “What was my clinical probability before the test?” If nobody considered pulse, oxygen saturation, one-sided leg swelling, recent surgery, estrogen therapy, cancer, or previous VTE, the result may have been interpreted too narrowly.

Ask for the plan in writing if you can: symptoms to watch, whether ultrasound is needed, whether CT is needed, and whether repeat testing makes sense. Our variado de sangoanalizo guide helps patients understand why small lab shifts should not be read like stock prices.

I usually tell patients to keep three numbers handy: D-dimer value with unit, oxygen saturation if measured, and resting pulse. Those three numbers, paired with symptoms, often tell the clinician much more than the D-dimer flag alone.

Bottom line: use age adjustment, but do not ignore symptoms

Age-adjusted D-dimer after 50 is a smart way to reduce unnecessary imaging, but it is only safe inside a structured clinical assessment. Use age × 10 ng/mL FEU for many assays, verify the unit, and seek urgent care when symptoms suggest PE or DVT.

As of June 13, 2026, my practical rule is this: a low-risk 74-year-old with D-dimer 680 ng/mL FEU may avoid CT, but a breathless 74-year-old with pulse 120/min and oxygen 91% needs urgent assessment. The same number can mean different things.

Kantesti’s medical content is reviewed against clinical standards, not just lab reference intervals. Our klinika validigo page explains how physician oversight and technical benchmarking shape the way we present risk language.

If your D-dimer is borderline, do not argue with the number in isolation. Ask whether your age-adjusted cutoff was used, whether your symptoms change pretest probability, and whether ultrasound or CT is needed today.

The safe interpretation is humble. D-dimer is excellent at ruling out clots in the right patient group, poor at proving clots, and dangerous when used to overrule a high-risk clinical story.

Oftaj Demandoj

Kio estas la aĝ-adaptita sojlo de D-dimero post la aĝo de 50?

La kutima aĝ-adaptita D-dimera sojlo post la aĝo 50 estas aĝo × 10 ng/mL FEU. Ekzemple, la sojlo estas 600 ng/mL FEU je la aĝo 60, 750 ng/mL FEU je la aĝo 75, kaj 880 ng/mL FEU je la aĝo 88. Tiu regulo uziĝu nur kiam la klinika probablo de koagulaĵo estas malalta aŭ meza, ne kiam simptomoj forte sugestas pulman embolion aŭ profundan vejnan trombozon (DVT).

Ĉu D-dimero de 700 estas alta ĉe 70-jaraĝulo?

D-dimero de 700 ng/mL FEU estas ĝuste ĉe la kutima aĝ-adaptita sojlo por 70-jaraĝa. Ĝi povas esti traktata kiel negativa nur se la persono havas malaltan aŭ mezan klinikan probablon kaj neniujn koncernajn simptomojn kiel subita manko de spiro, brustdoloro, svenado, malalta oksigeno, tusado de sango, aŭ unu ŝvelinta dolora kruro. Se la unuo estas DDU anstataŭ FEU, 700 ng/mL DDU ne estas ekvivalenta kaj postulas malsaman interpretadon.

Kial D-dimero pliiĝas kun aĝo?

D-dimero pliiĝas kun aĝo ĉar baza fibrina formado kaj malkomponiĝo iĝas pli aktivaj dum sangaj vaskuloj, histoj kaj inflamaj sistemoj maljuniĝas. Pli maljunaj plenkreskuloj ankaŭ havas pli altajn indicojn de infekto, kancero, rena difekto, korinsuficienco, kirurgio kaj hospitaligo, ĉio el kio povas altigi D-dimeron super 500 ng/mL FEU sen pruvi sangokoagulaĵon. Tial aĝ-adaptitaj sojloj reduktas falsajn pozitivajn rezultojn post la aĝo de 50.

Ĉu normala, al aĝo adaptita D-dimero povas maltrafi sangokoagulaĵon?

Jes, normala aĝ-adaptita D-dimero povas preteratenti sangokoagulaĵon en elektitaj situacioj, precipe se klinika probablo estas alta, simptomoj ĉeestis dum 10 ĝis 14 tagoj, antikoagulantoj estis komencitaj antaŭ testado, aŭ se la koagulaĵo estas malgranda. D-dimero estas plej sekura kiel ekskluda testo ĉe pacientoj kun malalta aŭ meza risko. Alt-riskaj simptomoj devus konduki al bildigo prefere ol trankviligo pro limregiona nombro.

Kiaj simptomoj postulas bildigon eĉ kun iomete levita D-dimero?

Subita mallongigo de spiro, brustdoloro kiu plimalboniĝas kun spirado, svenado, oksigensaturiĝo sub ĉirkaŭ 92%, tusado de sango, pulso super 100/min, aŭ unu ŝvelinta dolora kruro povas pravigi urĝan bildigon eĉ kiam D-dimero estas ĉe la limo. Bildigo povas signifi CT-pulman angiografion, V/Q-skanadon, aŭ kunpremajn ultrasonojn depende de la klinika situacio. La rezulto de D-dimero ne devus superregi alt-riskan simptoman ŝablonon.

Qual estas la diferenco inter FEU kaj DDU en rezultoj de D-dimero?

FEU kaj DDU estas malsamaj raportaj sistemoj por D-dimero, kaj FEU-valoroj estas proksimume duoble pli grandaj ol DDU-valoroj. Norma limvaloro de 500 ng/mL FEU estas proksimume ekvivalenta al 250 ng/mL DDU. Formuloj adaptitaj laŭ aĝo kutime estas skribitaj por FEU kiel aĝo × 10 ng/mL post aĝo 50, dum proksimuma DDU-ekvivalento estas aĝo × 5 ng/mL.

Ĉu mi ripetu liman D-dimero-teston?

Ripeti liman D-dimeron povas esti akceptebla kiam simptomoj estas malalt-riska, la origina unuo estis neklara, aŭ la rezulto okazis dum provizora ellasilo kiel milda infekto. Ripeto post 1 ĝis 2 semajnoj povas montri ĉu la valoro malpliiĝas, ekzemple de 1 100 al 520 ng/mL FEU. Ne atendu ripetan testadon se vi havas brustdoloron, mankon de spiro, svenon, malaltan oksigenon aŭ unu ŝvelintan doloran kruron.

Akiru hodiaŭ AI-movitan analizon de sangoanalizo

Aliĝu al pli ol 2 milionoj da uzantoj tutmonde, kiuj fidas je Kantesti por tuja, preciza analizo de laboratoriaj testoj. Alŝutu viajn rezultojn de sangoanalizo kaj ricevu ampleksan interpretadon de 15,000+-biomarkiloj en sekundoj.

📚 Referencitaj esplorpublikaĵoj

1

Klein, T., Mitchell, S., & Weber, H. (2026). Gvidilo pri Virina Sano: Ovulado, Menopaŭzo kaj Hormonaj Simptomoj. Kantesti AI Medicina Esploro.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Multilingual AI Assisted Clinical Decision Support for Early Hantavirus Triage: Design, Engineering Validation, and Real-World Deployment Across 50,000 Interpreted Blood Test Reports. Kantesti AI Medicina Esploro.

📖 Eksteraj medicinaj referencoj

3

Righini M et al. (2014). Aĝ-adaptitaj D-dimeraj limvaloroj por ekskludi pulman embolion: la studo ADJUST-PE. JAMA.

4

Konstantinides SV et al. (2020). 2019 ESC-Gvidlinioj por la diagnozo kaj administrado de akuta pulma embolio ellaboritaj kunlaborante kun la Eŭropa Spira Societo. Eŭropa Kora Revuo.

5

Kearon C et al. (2019). Diagnosis of Pulmonary Embolism with D-Dimer Adjusted to Clinical Probability. New England Journal of Medicine.

2M+Testoj Analizitaj
127+Landoj
75+Lingvoj

⚕️ Medicina Deklaro

Signaloj de fido E-E-A-T

Sperto

Kuracista gvidata klinika revizio de laboratoriaj interpretaj laborfluoj.

📋

Kompetenteco

Laboratoria medicino fokusiĝas pri kiel biomarkiloj kondutas en klinika kunteksto.

👤

Aŭtoritateco

Skribita de d-ro Thomas Klein kun revizio de d-ro Sarah Mitchell kaj prof. d-ro Hans Weber.

🛡️

Fidindeco

Evident-bazita interpretado kun klaraj sekvaj vojoj por redukti alarmon.

🏢 Kantesti LTD Registrita en Anglio kaj Kimrio · Kompanio n-ro. 17090423 Londono, Unuiĝinta Reĝlando · kantesti.net
blank
De Prof. Dr. Thomas Klein

D-ro Thomas Klein estas estrar-atestita klinika hematologo, kiu funkcias kiel Ĉefa Medicina Oficiro ĉe Kantesti AI. Kun pli ol 15 jaroj da sperto en laboratoriamedicino kaj forta intereso pri AI-subtenata interpretado de rezultoj de sangoanalizo, li laboras por ligi novan teknologion kun ĉiutaga klinika praktiko. Liaj areoj de intereso inkluzivas analizon de biomarkiloj, esploradon pri klinika decidsubteno kaj optimumigon de referencaj intervaloj specifaj por populacio. Kiel CMO, li kontribuas klinikan enigon al la interna komparnormado de la platformo kaj provizas klinikan superrigardon por la medicina kvalito de la edukaj raportoj de Kantesti.

Respondi

Retpoŝtadreso ne estos publikigita. Devigaj kampoj estas markitaj *